Archive for the ‘Treatment’ Category

March 2018 Support Group – Laser Therapy

Our next support meeting will be Saturday, March 31, from 2:30-4:30 at the Pinney Library.  

The featured speaker will be Raymond Yingling of Madison Laser Therapy http://www.madisonlasertherapy.com. Ray attended Clayton College school and is a certified a naturopath, especially trained in drug induced nutrient depletion. He is former owner of Vita Source a local vitamin store in Madison. Presently, Ray owns Madison Laser Therapy and has been treating people with Class 4 infrared laser for over 7 years.

http://   Approx. 4 Min.

High intensity laser – medical effects

Published on Dec 1, 2015

  • Class IV lasers may offer better therapeutic outcome, based on six characteristics of this new technology:  Class IV lasers can deliver up to 1,500 times more energy than Class III and consequently reduce treatment time because and thus dosages of therapeutic energy.
  • Deeper penetration into the body. Leading Class III lasers only penetrate 0.5-2.0 cm. Class IV can penetrate up to 10 cm.
  • Larger treatment surface area.Class III cover a treatment area of 0.3-5.0 cm2 while Class IV cover up to 77 cm2.
  • Greater power density.Power density indicates the degree of concentration of the power output. This property has been shown to play a major role in therapeutic outcomes.
  • Continuous power supply.In Class III lasers, the power is pulsed or modulated approximately 50 percent of the time. In other words, light is permitted to pass through the probe for only 50 percent of the total operating time. In most cases, Class IV lasers deliver a consistent amount of energy over a given time. Their power can be adjusted for acute and chronic conditions.
  • Superior fiber optic cables. Fiber optic cables transmit laser energy from the laser to the treatment probe (wand) at the end of the cable. Several studies reveal that as much as 50 percent of the light energy generated by a Class III laser may be lost by the time it reaches the end of the probe.

Class IV laser therapy has demonstrated the ability to significantly accelerate and enhance the body’s natural defense and repair components in the presence of injury, inflammation and certain disease processes through the action of photo-stimulation of light reactive biological receptors (chromophores) in the body.  Laser therapy is consistent in providing pain relief, reducing injury damage and loss of function by modifying the effects and limiting the duration of inflammation, as well as enhancing specific repair and healing processes, and facilitating more rapid repair and producing stronger healed tissue structures.

Multiple clinical studies have noted the following results of Laser therapy:
• Increased collagen production
• Enhanced nerve regeneration
• Increased vasodilatation
• Reduced inflammatory duration
• Increased cell metabolism
• Increased pain threshold
• Increased cell membrane potential
• Reduced edema magnitude
• Increased microcirculation
• Increased tissue and bone repair
• Increased lymphatic response

Lasers work when light receptive chromophores are irradiated with coherent laser light.  The transferred energy stimulates increased action in cellular and sub-cellular tissues.  Penetrating much deeper than other incoherent light wave forms, laser light activates increased mitochondrial ATP synthesis, mitigates mast cell inflammation and increases Ca++ ion presence and beneficial reactive oxygen species (ROS) production. Through the action of photo bio-stimulation, oxidative metabolism is increased via cytochrome C oxidase and photosensitization of hemoglobin.  Laser irradiation stimulates increased endorphin release and increased prostaglandin synthesis.  Photon-stimulation leads to both localized and systemic reactions that result in immunomodulation and reduction of inflammation.  Damaged skeletal, connective and neurological tissues and structures react with enhanced healing with lasers.

class_iv_therapy_laser_case_studies_report_2013

I have personally had treatments with the Class IV laser and noticed near immediate improvement in pain and stiffness.

Recommendations for the TBD Working Group

https://www.change.org/p/1120418/u/22432830?utm_medium=email&utm_source=petition_update&utm_

Subcommittee recommendations for the TBD Working Group

Carl Tuttle

Hudson, NH

FEB 25, 2018 — Please see the following letter addressed to the Tick Borne Disease Working Group.

If you support a congressional investigation into the mishandling of Lyme disease as this petition is calling for please consider writing your own letter in support of this request to form a separate subcommittee.

Anyone wishing to contact the Lyme Disease Working Group can send an email to:
tickbornedisease@hhs.gov

Carbon copy to Dr. John Aucott, Chair of the TBD Working Group:
jaucott2@jhmi.edu

Richard Wolitski, Ph.D., Designated Federal Officer:
Richard.Wolitski@hhs.gov

Letter to the Working Group:

To the TBD Working Group,

Let’s not ignore the fact that a crime has been identified here! 

Racketeering lawsuit: https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

A subcommittee should be appointed to uncover the motivation behind the deliberate suppression of evidence of persistent Borrelia infection so this travesty will never be repeated.

For example:

1. Why did the Centers for Disease Control suppress positive culture evidence of persistent infection (1991) in Lyme patient Vicki Logan as described in the letter to Brenda Fitzgerald, Director of the CDC?

Letter to Fitzgerald: https://www.dropbox.com/s/xaul84dqmqgbre0/Brenda%20Fitzgerald%20MD%20Director%20CDC.docx?dl=0

2. Why was the following 1995 case study out of Stony Brook Lyme Clinic ignored which describes seronegative recurrent Borrelia infection after repeated courses of IV and oral meds?

Seronegative Chronic Relapsing Neuroborreliosis.
https://www.ncbi.nlm.nih.gov/pubmed/7796837

________________

3. Why did the Centers for Disease Control promote Nordin Zeidner who published his study regarding single dose Doxycycline for tick bite?

Zeidner’s conclusion: https://www.ncbi.nlm.nih.gov/pubmed/18349366

“…..single dose doxy stopped Lyme disease not in 87% of mice, but rather, in 20 to 30 percent at most.

Dr Gary Wormser of New York Medical College (who has controlled the Lyme disease narrative for the past three decades) published a study earlier promoting the use of single dose Doxy for tick bite. (See Wormser’s 2001 flawed NEJM article)

Source: http://www.nejm.org/doi/full/10.1056/NEJM200107123450201

I understand that it was Wormser who called Zeidner’s superiors at the CDC to put an end to Zeidner’s work. Zeidner was told to discard the mice sera instead of testing for antibodies as he had promised.

Zeidner’s research was terminated for “lack of industrial support” Paul Mead, and he was promoted, and his email address inactivated.

Wormser’s single dose Doxycycline is still promoted to this day.

Complaint filed with the Office of Special Counsel and Office of Inspector General:

https://www.dropbox.com/s/68fq6cit7ggqhdt/Single%20dose%20Doxy%20Complaint%20filed%20with%20the%20Office%20of%20Special%20Counsel.docx?dl=0

How many other researchers have been intimidated or have had their employment threatened by Wormser or the CDC?

___________________

4. Why have the Centers for Disease Control bankrolled Wormser’s junk science (1.5 million) where he compares Lyme to the “aches and pains of daily living”; essentially downgrading Lyme with its life-altering/life-threatening consequences to a simple “nuisance disease?”

The patient experience with this disease does not resemble the established disease definition (Wormser’s definition) as the destructive nature is seen in histopathologic findings of the autopsy results of Lyme patient Vicki Logan.

Complaint filed with the Office of Research Integrity:

https://www.dropbox.com/s/94jv3w2hb0z9lv7/Email%20sent%20to%20the%20Office%20of%20Research%20Integrity.docx?dl=0

Complaint filed with the U.S. Department of Justice, Criminal Division:

https://www.dropbox.com/s/8ts9v51pr2fn65b/Complaint%20filed%20with%20the%20U.S.%20Department%20of%20Justice%20Criminal%20Division.docx?dl=0

Scientific misconduct to support one’s bias is fraud which has had an impact on public health and clinical treatment. Wormser’s 1.5 million grant should be reclaimed from New York Medical College to support honest research.

________________

5. Why did the Centers for Disease Control end all communication with Dr. Sin Lee after he published his study identifying persistent Borrelia infection from the blind coded serum samples provided by the CDC’s Lyme Disease Clinical Sample Repository? A FOIA request identified Wormser’s lab which collected and categorized these samples. Dr. Lee’s laboratory used molecular diagnostics with sequencing confirmation.

Dr. Lee’s publication identifying chronic Lyme:

DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections.
https://www.ncbi.nlm.nih.gov/pubmed/24968274

Dr. Lee’s 57 million dollar claim against the CDC for suppression of an early detection test for Lyme disease: 
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/20864023

____________________

6. How many other laboratory tests for Lyme disease are sitting on the shelf?

Quantification of Borrelia burgdorferi membrane proteins in human serum is a new concept for detection of bacterial infection
Crystal S. F. Cheung, Kyle W. Anderson, Kenia Y. Villatoro Benitez, Mark J. Soloski, John N. Aucott, Karen W. Phinney, and Illarion V. Turko,
https://www.ncbi.nlm.nih.gov/pubmed/26491962

Perhaps Dr. Aucott could shed some light on the subject since he is a co-author of this 2015 paper?

7. For the past three decades, the patient experience with Lyme disease describes an illness producing horrific disability and financial ruin but those who control the narrative through editorial censorship have painted an entirely different picture. Why?

Here is a small sample of the published books on the subject of Lyme disease: (I listed these seven books for a reason!)

1. Cure Unknown: Inside the Lyme Epidemic by Pamela Weintraub

“Instead of just swollen knees and a rash, patients can experience exhaustion, disabling pain, and a “Lyme fog” that leaves them dazed and confused.”

2. In the Crucible of Chronic Lyme Disease: Collected Writings & Associated Materials
by Kenneth B. Liegner

“Documentational in nature and not written as a narrative, the materials, nonetheless, convey the intensity of the struggle to characterize the nature of Lyme disease and the desperate fight for proper diagnosis and treatment upon the outcome of which patients’ very lives depended.”

3. Lyme Madness: Rescuing My Son Down The Rabbit Hole of Chronic Lyme Disease by Lori Dennis

Chronic Lyme disease is a complicated, confusing, and terrifying abyss—a black hole of human suffering, conflicting views, widespread corruption, and unrelenting medical navigation. Lyme Madness chronicles the author’s and adult son’s medical odyssey while capturing the current landscape of immeasurable suffering,

4. Confronting Lyme Disease: What Patient Stories Teach Us by Rita L. Stanley, Karen P. Yerges

“In this book, fourteen patients reveal how their lives were changed by the debilitating effects of Lyme disease and its co-infections, and by unanticipated medical obstacles.”

5. “It’s All In Your Head,” Patient Stories From the Front Lines: Intimate Aspects of Chronic and Neuropsychiatric Lyme Disease by PJ Langhoff

“Imagine inaccurate diagnostic tests…Physicians ignoring patient symptoms…Insurance denying coverage…patients are told their illness is “fake”…Academic societies denying an epidemic…People are suffering needlessly…Sound like science fiction? It’s real and it’s happening right now…”

6. Believe Me: My Battle with the Invisible Disability of Lyme Disease By Yolanda Hadid

“She suffered from severe debilitating fatigue, migraines, joint pain, anxiety, insomnia, Bell’s palsy, tremors, muscle weakness, severe brain fog, word retrieval difficulty, memory loss and intermittent loss of eyesight.”

7. Bite Me: How Lyme Disease Stole My Childhood, Made Me Crazy, and Almost Killed Me by Ally Hilfiger, Tommy Hilfiger (Foreword by)

“Ally was at a breaking point when she woke up in a psych ward at the age of eighteen. She couldn’t put a sentence together, let alone take a shower, eat a meal, or pick up a phone.”

______________

There is evidence to suggest that the rush to create a vaccine for Lyme led to the mishandling of the disease. The Principle Investigators of the two previous Lyme vaccines: Allen C. Steere for SmithKlineBeecham’s LymeRix and Gary Wormser for Connaught’s vaccine (which never made it to market) have conceptualized a disease that would enable vaccine development.

A chronic relapsing seronegative disease does not fit the vaccine model.

The one-size-fits-all Lyme treatment guideline (lead author: Gary Wormser) matches the conceptualized disease. (Nuisance disease) This is a flagrant conflict of interest. Post-treatment Lyme disease syndrome is simply a fabricated medical condition disguising treatment failure.

Lyme disease testing parameters were manipulated at the 1994 Dearborn Conference in order to facilitate vaccine development. Outer surface proteins A and B of the Borellia spirochete were eliminated so the vaccinated would test seronegative. Removing Bands 31 and 34 from the commercial Western blot is the crime that should be exposed.

Letter to the World Health Organization regarding faulty/misleading antibody tests:

https://www.dropbox.com/s/olby3eb9276oj3r/11th%20email%20to%20the%20World%20Health%20Organization.docx?dl=0

8. Why did CDC Director Thomas Frieden refuse to answer Dr. David Volkman’s letter regarding the strict DEARBORN testing criteria?

Dr. Volkman’s letter to Frieden:

https://www.dropbox.com/s/sl5x3gzguowpj6n/Volkman%20letter%20to%20Frieden.doc?dl=0
_________________________

Might I remind everyone that this process of collecting data and recommending changes for how we diagnose and treat Lyme disease was previously completed in 2001 by the Institute of Medicine. What has changed since then? NOTHING!

IDSA Ignores IOM Recommendations in Lyme Disease Treatment Guidelines’ Development, According to the Lyme Disease Association & LymeDisease.org
May 06, 2015, 13:40 ET from Lyme Disease Association, Inc.
https://www.prnewswire.com/news-releases/idsa-ignores-iom-recommendations-in-lyme-disease-treatment-guidelines-development-according-to-the-lyme-disease-association–lymediseaseorg-300078777.html?tc=eml_cleartime

Excerpt:

“Unfortunately for 300,000 people who contract Lyme annually in the US, the last 25 years of research has not improved patient care. Instead, a small group of researchers have built their careers around a biased view of the disease that brings us no closer to cure. They have disregarded patients while pursuing dead- end research using tax payer funded grants.”

___________

What is the solution here?

The TBD Working Group subcommittee should recommend a congressional investigation (with subpoena power) into the deliberate mishandling of Lyme disease and present all of the evidence collected by the subcommittee members with the intent to prosecute those responsible for this crime against humanity as it would appear that the Centers for Disease Control is allowed to police themselves while answering to no one.

The disabled Lyme community believes that this TBD Working Group is little more than a pacifier while those in control march along with current agendas supporting the status quo.

For example:

Once again we see the CDC promoting antibody testing for Lyme even though it is well known that Lyme patients may not produce detectable antibodies for 4-6 weeks after a tick bite.

A multiplex serologic platform for diagnosis of tick-borne diseases
Published online: 16 February 2018
https://www.nature.com/articles/s41598-018-21349-2
Rafal Tokarz, Nischay Mishra, Teresa Tagliafierro, Stephen Sameroff, Adrian Caciula, Lokendrasingh Chauhan, Jigar Patel, Eric Sullivan, Azad Gucwa, Brian Fallon, Marc Golightly, Claudia Molins, Martin Schriefer, Adriana Marques, Thomas Briese & W. Ian Lipkin

Until the CDC, IDSA and all those named in the racketeering lawsuit have been removed from positions of authority and influence we will have another three decades of unimaginable pain and suffering.

A response to this inquiry is requested.

Respectfully submitted,

Carl Tuttle
Independent Researcher
Lyme Endemic Hudson, NH

One Million Predicted to Get Lyme in 2018 in the U.S.

http://www.mdpi.com/2227-9032/6/1/16

The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic

Marcus Davidsson
Economist and Independent Researcher,

https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=895329
Published: 13 February 2018

Abstract
1 million people are predicted to get infected with Lyme disease in the USA in 2018.

healthcare-06-00016-g011Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected with Lyme disease in Europe in 2018.

In the USA by 2050, 55.7 million people (12% of the population) will have been infected with Lyme disease. In Europe by 2050, 134.9 million people (17% of the population) will have been infected with Lyme disease. Most of these infections will, unfortunately, become chronic.

healthcare-06-00016-g017

The estimated treatment cost for acute and chronic Lyme disease for 2018 for the USA is somewhere between 4.8 billion USD and 9.6 billion USD and for Europe somewhere between 10.1 billion EUR and 20.1 billion EUR.

If governments do not finance IV treatment with antibiotics for chronic Lyme disease, then the estimated government cost for chronic Lyme disease for 2018 for the USA is 10.1 billion USD and in Europe 20.1 billion EUR. If governments in the USA and Europe want to minimize future costs and maximize future revenues, then they should pay for IV antibiotic treatment up to a year even if the estimated cure rate is as low as 25%. The cost for governments of having chronic Lyme patients sick in perpetuity is very large.

View Full-Text:  http://www.mdpi.com/2227-9032/6/1/16/htm

_____________

**Comment** 

Davidsson writes in his conclusion:

 I am convinced that the history books in the future will describe controversy that exists today regarding chronic Lyme disease as one of the most shameful affairs in medicine.

Amen.

And this is just for Lyme (borrelia).  Imagine the added costs of coinfections.

 

 

 

 

Immediate Attention: Illinois Lyme Doctor Protection Bill #4515

http://ilga.gov/house/committees/members.asp?committeeID=1948

This Illinois Bill #4515 affects ALL Illinois Lyme patients! Other states were successful in passing similar Bills…..now let’s show them that we NEED this Bill to pass in Illinois.

Contact information for this Bill is listed in link above. Please contact each and every member on this committee and let them know why we need this Bill to pass!

Synopsis As Introduced:

Amends the Medical Practice Act of 1987.

Exempts physicians from disciplinary action by the Department of Financial and Professional Regulation based solely upon the licensee’s recommendation or provision of a treatment method for Lyme disease or other tick-borne disease if specified criteria are met.

 

 

 

Maryland Working to Get Insurance to Cover Proper Lyme Treatment

https://www.lymedisease.org/maryland-lyme-insurance-bill/

Maryland legislature to hold hearings on Lyme insurance bill

The Maryland General Assembly will hold a hearing next week on HB 880, a bill to require insurance companies to cover treatment for Lyme disease.

It is a companion measure to SB 793, which will be considered by the state senate.

The measures are officially titled “Health Insurance- Lyme Disease and Related Tick-Borne Illnesses- Long -Term Antibiotic Treatment.” They have been introduced by Delegate Karen Lewis-Young and Senator Brian Feldman.

Long-term antibiotic treatment is defined as any term exceeding 28 days. The bill states, in part:

IF THE LONG–TERM ANTIBIOTIC TREATMENT OF LYME DISEASE AND RELATED TICK–BORNE ILLNESSES HAS BEEN ORDERED BY A LICENSED TREATING PHYSICIAN FOR THERAPEUTIC PURPOSES, AN ENTITY SUBJECT TO THIS SECTION:

(1) SHALL PROVIDE COVERAGE FOR THE FULL LENGTH OF THE LONG–TERM ANTIBIOTIC TREATMENT TO BE ADMINISTERED IN THE MANNER PRESCRIBED BY THE LICENSED TREATING PHYSICIAN; AND

(2) MAY NOT IMPOSE A QUANTITATIVE LIMITATION ON THE 24 LONG–TERM ANTIBIOTIC TREATMENT

Click here to read the entire bill: https://www.lymedisease.org/wp-content/uploads/2018/02/Maryland-HB-880.pdf

If you are a Maryland resident, click here to contact your legislators:  https://www.votervoice.net/NATCAPLYME/Campaigns/57027/Respond